Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphangioleiomyomatosis 1 Breast Neoplasms 1

Interventions

Sirolimus 4 nintedanib 1 Sugars 1 Resveratrol 1 Octreotide 1 Loratadine 1 Letrozole 1 Everolimus 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphangioleiomyomatosis × Loratadine × Clear all

NCT05190627 2022-01-27

LORALAM

Institut d'Investigació Biomèdica de Bellvitge

Phase 2 Unknown

Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡